Literature DB >> 9150444

Biology of TGF-beta in knockout and transgenic mouse models.

E P Böttinger1, J J Letterio, A B Roberts.   

Abstract

This paper reviews the basic biology and biochemistry of the TGF-beta isoforms including their unique serine-threonine receptors and signaling intermediates. Dysregulation of TGF-beta expression and/or receptor/signaling function have been implicated in a wide variety of pathologies. We will discuss mechanisms underlying some of these disease processes as gained from study of transgenic mice in which expression of TGF-beta 1 has either been lost by targeted deletion of its gene, is overexpressed in a tissue-specific manner, or blocked by its latency associated peptide.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150444     DOI: 10.1038/ki.1997.185

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  32 in total

1.  Latency-associated peptide of transforming growth factor beta enhances mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice.

Authors:  K A Wilkinson; T D Martin; S M Reba; H Aung; R W Redline; W H Boom; Z Toossi; S A Fulton
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 2.  Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease.

Authors:  P J Stahl; D Felsen
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

3.  Apoptosis in gingival overgrowth tissues.

Authors:  A Kantarci; P Augustin; E Firatli; M C Sheff; H Hasturk; D T Graves; P C Trackman
Journal:  J Dent Res       Date:  2007-09       Impact factor: 6.116

4.  Integrin-mediated transforming growth factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit.

Authors:  Jun Araya; Stephanie Cambier; Alanna Morris; Walter Finkbeiner; Stephen L Nishimura
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures.

Authors:  M E Harris-White; T Chu; Z Balverde; J J Sigel; K C Flanders; S A Frautschy
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

6.  Interleukin (IL)-6 modulates transforming growth factor-β receptor I and II (TGF-βRI and II) function in epidermal keratinocytes.

Authors:  Lerin R Luckett-Chastain; Mackenzie L Cottrell; Bethany M Kawar; Michael A Ihnat; Randle M Gallucci
Journal:  Exp Dermatol       Date:  2017-03-08       Impact factor: 3.960

7.  Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues.

Authors:  Wei He; Allen G Li; Dongyan Wang; Shuhua Han; Biao Zheng; Marie-José Goumans; Peter Ten Dijke; Xiao-Jing Wang
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

8.  Smad3 knock-out mice as a useful model to study intestinal fibrogenesis.

Authors:  Giuliana Zanninelli; Antonella Vetuschi; Roberta Sferra; Angela D'Angelo; Amato Fratticci; Maria Adelaide Continenza; Maria Chiaramonte; Eugenio Gaudio; Renzo Caprilli; Giovanni Latella
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

Review 9.  The roles of growth factors in tendon and ligament healing.

Authors:  Timothy Molloy; Yao Wang; George Murrell
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

10.  Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.

Authors:  Andrea Hartner; Karl F Hilgers; Markus Bitzer; Roland Veelken; Harald O Schöcklmann
Journal:  J Mol Med (Berl)       Date:  2002-12-14       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.